Professor Jan Rehwinkel is named EMBO Young Investigator

Protecting lactoferrin for iron delivery: Effects of matrix composition and iron loading on gastric stability

Blanco-Doval A. et al, (2026), Food Hydrocolloids, 174

The 9th International RASopathies Symposium.

Castel P. et al, (2026), Am J Med Genet A

A functional overlap between actively transcribed genes and chromatin insulator elements.

Cornell LJ. et al, (2026), EMBO J

Gain and Loss of FLT3 Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO).

Papayannidis C. et al, (2026), Oncol Ther

A mechanism to initiate emergency type 2 myelopoiesis.

Fagnan A. et al, (2026), Nature

Protocol for stable cell line production to express muscle-type nicotinic receptor.

Li A. et al, (2026), STAR Protoc, 7

Expanding the phenotypic spectrum associated with ZIC1 variants: a neurodevelopmental disorder with and without craniosynostosis

TWIGG S., (2026), Genetics in Medicine

Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction.

Zhang K. et al, (2026), Science, 391

RLevolution: Unravelling the history of genomic instability through deep reinforcement learning

AHMED A., (2026), Royal Society Open Science

Engineering bone-marrow in a dish - a bloody business: Pre-clinical opportunities, translational use-cases, and a call for consensus.

North D. et al, (2026), J Thromb Haemost

BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs.

Ng HL. et al, (2026), Adv Sci (Weinh)

Context-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis.

Zhang P. et al, (2026), Nat Commun

FACT safeguards promoter topology by maintaining nucleosomes and restricting chromatin factor spreading

Dopico-Fernandez AM. et al, (2026)

Facilitators may represent a new class of regulatory elements.

Kassouf M. et al, (2026), Curr Opin Genet Dev, 97

Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

Barker CG. et al, (2026), Mol Syst Biol

Signalome-wide mapping of the NFκB pathway in T-cells reveals novel targets for immunotherapy

Clarke J. et al, (2026)

ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression.

Shen Y. et al, (2026), Nat Commun

High-throughput monoclonal gammopathy community monitoring programme.

Agarwal G. et al, (2026), Br J Haematol

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.

Beck DB. et al, (2026), J Clin Med, 15

Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Mecklenbrauck R. et al, (2026), Leukemia

Search results

Showing results for